American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers
Menée en 2011 auprès de 212 cabinets de consultation oncologique aux Etats-Unis, cette étude analyse leurs pratiques de collecte d'information sur l'histoire familiale de leurs patients et leurs prescriptions de consultation oncogénétique
Approximately 5% to 10% of cancers are attributable to a hereditary cancer predisposition syndrome. Identifying those patients with cancer who have an inherited cancer predisposition syndrome has significant benefit both to the patient and to at-risk relatives. In addition, oncology patients’ short- and long-term management can be personalized based on their genetic status...
Journal of Clinical Oncology , commentaire, 2014